Valentina Poletti

632 total citations
22 papers, 450 citations indexed

About

Valentina Poletti is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Valentina Poletti has authored 22 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Genetics and 7 papers in Genetics. Recurrent topics in Valentina Poletti's work include Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (9 papers) and RNA Interference and Gene Delivery (8 papers). Valentina Poletti is often cited by papers focused on Virus-based gene therapy research (17 papers), CRISPR and Genetic Engineering (9 papers) and RNA Interference and Gene Delivery (8 papers). Valentina Poletti collaborates with scholars based in Italy, France and United States. Valentina Poletti's co-authors include Fulvio Mavilio, Alessandra Biffi, Annarita Miccio, Giuliana Ferrari, Michael Rothe, Sabine Charrier, Axel Schambach, Enzo Di Iorio, Marcela Del Río and Giulietta Maruggi and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Valentina Poletti

21 papers receiving 443 citations

Peers

Valentina Poletti
Carmencita E. Nicolas United States
Elke Grassman United States
Phillip A. Doerfler United States
Michael L. Kaufman United States
Lin Ye United States
Carmencita E. Nicolas United States
Valentina Poletti
Citations per year, relative to Valentina Poletti Valentina Poletti (= 1×) peers Carmencita E. Nicolas

Countries citing papers authored by Valentina Poletti

Since Specialization
Citations

This map shows the geographic impact of Valentina Poletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valentina Poletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valentina Poletti more than expected).

Fields of papers citing papers by Valentina Poletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valentina Poletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valentina Poletti. The network helps show where Valentina Poletti may publish in the future.

Co-authorship network of co-authors of Valentina Poletti

This figure shows the co-authorship network connecting the top 25 collaborators of Valentina Poletti. A scholar is included among the top collaborators of Valentina Poletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valentina Poletti. Valentina Poletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Sabyasachi, Annita Montepeloso, Guillaume Corre, et al.. (2024). An empowered, clinically viable hematopoietic stem cell gene therapy for the treatment of multisystemic mucopolysaccharidosis type II. Molecular Therapy. 32(3). 619–636. 2 indexed citations
2.
Peviani, Marco, et al.. (2023). An innovative hematopoietic stem cell gene therapy approach benefits CLN1 disease in the mouse model. EMBO Molecular Medicine. 15(4). e15968–e15968. 6 indexed citations
3.
Poletti, Valentina, Annita Montepeloso, Danilo Pellin, & Alessandra Biffi. (2023). Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells. Molecular Therapy — Methods & Clinical Development. 31. 101131–101131. 4 indexed citations
4.
Brusson, Mégane, Anne Chalumeau, Oriana Romano, et al.. (2023). Novel lentiviral vectors for gene therapy of sickle cell disease combining gene addition and gene silencing strategies. Molecular Therapy — Nucleic Acids. 32. 229–246. 11 indexed citations
5.
Poletti, Valentina & Fulvio Mavilio. (2021). Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases. Viruses. 13(8). 1526–1526. 52 indexed citations
6.
Poletti, Valentina & Alessandra Biffi. (2019). Gene-Based Approaches to Inherited Neurometabolic Diseases. Human Gene Therapy. 30(10). 1222–1235. 25 indexed citations
7.
Gao, Nan Papili, Guillaume Corre, Valentina Poletti, et al.. (2019). Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid. Human Gene Therapy. 30(8). 1023–1034. 4 indexed citations
8.
Urbinati, Fabrizia, Katelyn E. Masiuk, Valentina Poletti, et al.. (2018). Gene Therapy for Sickle Cell Disease : A Lentiviral Vector Comparison Study. Human Gene Therapy. 29(10). 1153–1166. 27 indexed citations
9.
Poletti, Valentina, Sabine Charrier, Guillaume Corre, et al.. (2018). Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency. Molecular Therapy — Methods & Clinical Development. 9. 257–269. 33 indexed citations
10.
Lidonnici, Maria Rosa, Giacomo Mandelli, Claudia Rossi, et al.. (2018). Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia. Molecular Therapy — Methods & Clinical Development. 11. 9–28. 18 indexed citations
11.
Weber, Leslie, Valentina Poletti, Elisa Magrin, et al.. (2018). An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype. Molecular Therapy — Methods & Clinical Development. 10. 268–280. 25 indexed citations
12.
Miskey, Csaba, Elena Almarza, Valentina Poletti, et al.. (2018). Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors. Molecular Therapy. 26(4). 1137–1153. 52 indexed citations
13.
Poletti, Valentina, Fabrizia Urbinati, Sabine Charrier, et al.. (2018). Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease. Molecular Therapy — Methods & Clinical Development. 11. 167–179. 18 indexed citations
14.
Poletti, Valentina & Fulvio Mavilio. (2017). Interactions between Retroviruses and the Host Cell Genome. Molecular Therapy — Methods & Clinical Development. 8. 31–41. 52 indexed citations
15.
Romano, Oriana, Clelia Peano, Guidantonio Malagoli Tagliazucchi, et al.. (2016). Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment. Scientific Reports. 6(1). 24724–24724. 19 indexed citations
16.
Poletti, Valentina, Sabine Charrier, Samia Martin, et al.. (2016). Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1). Blood. 128(22). 4705–4705. 1 indexed citations
17.
Poletti, Valentina, Guidantonio Malagoli Tagliazucchi, Andrea Faedo, et al.. (2015). Genome-Wide Definition of Promoter and Enhancer Usage during Neural Induction of Human Embryonic Stem Cells. PLoS ONE. 10(5). e0126590–e0126590. 14 indexed citations
18.
Barbaro, V., et al.. (2013). Gene Therapy approaches for corneal diseases. Research Padua Archive (University of Padua). 87–112. 1 indexed citations
19.
Miccio, Annarita, Valentina Poletti, Claudia Rossi, et al.. (2011). The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a β-globin Transgene. PLoS ONE. 6(12). e27955–e27955. 19 indexed citations
20.
Nunzio, Francesca Di, Giulietta Maruggi, Stefano Ferrari, et al.. (2008). Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors. Molecular Therapy. 16(12). 1977–1985. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026